EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Synchronous Contralateral Breast Cancer Detected at Elective Bilateral Mastectomy: Incidence, Predictors, and Biomarker Concordance in the National Cancer Database

Jared Lim, Christian Gomez, Michael Haydon, Harnoor Singh

Clinical Breast Cancer · 2026

DOI: 10.1016/j.clbc.2026.08.009 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Jared Lim und 3 weiteren Autor:innen. Beteiligte Einrichtung: McGovern Medical School, UTHealth Houston, Houston, TX. Electronic address: jared.lim@uth.tmc.edu. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Neoplasms, Multiple Primary. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To determine the incidence and characteristics of synchronous contralateral breast cancer (SCBC) detected at elective bilateral mastectomy for unilateral breast cancer using the National Cancer Database (NCDB), and to identify factors associated with contralateral disease. MATERIALS AND METHODS: We performed a retrospective analysis of the NCDB Participant Use File (2022-2023) using newly introduced breast-specific surgery codes identifying bilateral mastectomy with contralateral removal. Patients with unilateral breast cancer who underwent bilateral mastectomy were identified (n = 13,931). SCBC was defined conservatively as SEQUENCE_NUMBER=01. Multivariable logistic regression with stepwise selection identified independent predictors. Probabilistic matching enabled concordance analysis of 336 paired tumors. RESULTS: Among 13,931 patients, 709 had SCBC (incidence 5.09%). Mean age was 57.7 ± 12.3 years. Most primary tumors were invasive (81.4%), HR+/HER2- (64.5%), node-negative (64.0%), and stage 0-IA (56.0%). Age was the strongest predictor, with 6.7-fold higher odds in patients ≥ 70 versus < 40 (odds ratios [OR] 6.68, 95% confidence intervals [CI], 4.58-9.76, P < .0001). Compared with HR+/HER2- tumors, other subtypes carried lower odds, with triple-negative disease lowest (OR 0.48, 95% CI, 0.35-0.65, P < .0001). Primary tumor size was not associated with SCBC (OR 1.001, P = .20). Discrimination was modest (c-statistic 0.669). In 336 matched pairs, contralateral tumors were smaller (median 11.5 mm vs. 18.5 mm) and predominantly early stage (61% stage 0-IA; 3.3% stage II+). Concordance was 86.8% for ER, 78.8% for HER2, 71.8% for PR, 67.0% for histology, and 42.6% for grade, with full concordance in 40.8%. CONCLUSION: SCBC is found in approximately 1 in 20 patients undergoing bilateral mastectomy for unilateral disease. Risk is driven by patient-level factors, particularly age and receptor subtype, rather than primary tumor burden. High biomarker discordance supports independent tumor origins and highlights the diagnostic value of contralateral mastectomy specimens in select populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMastectomyNeoplasms, Multiple PrimaryRetrospective StudiesIncidenceHumansFemaleMiddle AgedAgedRisk FactorsBiomarkers, TumorElective Surgical ProceduresUnited StatesDatabases, FactualAdultTumor Burden

Stichwörter der Autor:innen

Occult carcinomaReceptor subtypeRisk stratificationSecond primary malignancypreoperative MRI

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • McGovern Medical School, UTHealth Houston, Houston, TX. Electronic address: jared.lim@uth.tmc.edu.
  • McGovern Medical School, UTHealth Houston, Houston, TX.
  • Department of Diagnostic and Interventional Imaging, McGovern Medical School, UTHealth Houston, Houston, TX.

Zitieren

APA

Lim, J., Gomez, C., Haydon, M., & Singh, H. (2026). Synchronous Contralateral Breast Cancer Detected at Elective Bilateral Mastectomy: Incidence, Predictors, and Biomarker Concordance in the National Cancer Database. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.08.009

Vancouver

Lim J, Gomez C, Haydon M, Singh H. Synchronous Contralateral Breast Cancer Detected at Elective Bilateral Mastectomy: Incidence, Predictors, and Biomarker Concordance in the National Cancer Database. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.08.009

BibTeX
@article{Lim2026,
  author = {Lim, Jared and Gomez, Christian and Haydon, Michael and Singh, Harnoor},
  title = {Synchronous Contralateral Breast Cancer Detected at Elective Bilateral Mastectomy: Incidence, Predictors, and Biomarker Concordance in the National Cancer Database},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2026.08.009}
}
Kostenlos starten →